Dramatic Activation of Antibiotic Production in Streptomyces coelicolor by Cumulative Drug Resistance Mutations
- 1 May 2008
- journal article
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 74 (9), 2834-2840
- https://doi.org/10.1128/aem.02800-07
Abstract
We recently described a new method to activate antibiotic production in bacteria by introducing a mutation conferring resistance to a drug such as streptomycin, rifampin, paromomycin, or gentamicin. This method, however, enhanced antibiotic production by only up to an order of magnitude. Working with Streptomyces coelicolor A3(2), we established a method for the dramatic activation of antibiotic production by the sequential introduction of multiple drug resistance mutations. Septuple and octuple mutants, C7 and C8, thus obtained by screening for resistance to seven or eight drugs, produced huge amounts (1.63 g/liter) of the polyketide antibiotic actinorhodin, 180-fold higher than the level produced by the wild type. This dramatic overproduction was due to the acquisition of mutant ribosomes, with aberrant protein and ppGpp synthesis activity, as demonstrated by in vitro protein synthesis assays and by the abolition of antibiotic overproduction with relA disruption. This new approach, called “ribosome engineering,” requires less time, cost, and labor than other methods and may be widely utilized for bacterial strain improvement.Keywords
This publication has 35 references indexed in Scilit:
- Mutations in rsmG , Encoding a 16S rRNA Methyltransferase, Result in Low-Level Streptomycin Resistance and Antibiotic Overproduction in Streptomyces coelicolor A3(2)Journal of Bacteriology, 2007
- The global role of ppGpp synthesis in morphological differentiation and antibiotic production in Streptomyces coelicolor A3(2)Genome Biology, 2007
- Physiological Analysis of the Stringent Response Elicited in an Extreme Thermophilic Bacterium,Thermus thermophilusJournal of Bacteriology, 2006
- An rplKΔ29‐PALG‐32 mutation leads to reduced expression of the regulatory genes ccaR and claR and very low transcription of the ceaS2 gene for clavulanic acid biosynthesis in Streptomyces clavuligerusMolecular Microbiology, 2006
- Improvement of α-Amylase Production by Modulation of Ribosomal Component Protein S12 in Bacillus subtilis 168Applied and Environmental Microbiology, 2006
- Streptomycin‐resistant (rpsL) or rifampicin‐resistant (rpoB) mutation in Pseudomonas putida KH146‐2 confers enhanced tolerance to organic chemicalsEnvironmental Microbiology, 2002
- Novel Approach for Improving the Productivity of Antibiotic-Producing Strains by Inducing Combined Resistant MutationsApplied and Environmental Microbiology, 2001
- The antibiotic thiostrepton inhibits a functional transition within protein L11 at the ribosomal GTPase centreJournal of Molecular Biology, 1998
- Stationary‐phase production of the antibiotic actinorhodin in Streptomyces coelicolor A3(2) is transcriptionally regulatedMolecular Microbiology, 1993
- A relaxed (rel) mutant of Streptomyces coelicolor A3(2) with a missing ribosomal protein lacks the ability to accumulate ppGpp, A-factor and prodigiosinJournal of General Microbiology, 1990